Northwire Canada EditionFriday, October 16, 2026
Sign inSubscribe
Northwire
⌕
GOLD 4201.80 +0.8% SILVER 58.03 +1.5% COPPER 6.63 +1.2% OIL 95.64 −2.4% PALLADIUM 1124.50 −0.3% LIB 0.720 +0.0% NPR 0.620 +0.0% QZM 0.380 +0.0% BVA 0.760 +0.0% ONAU 0.520 +0.0% FMR 0.225 +0.0% GSVR 0.340 +0.0% PHNM 0.340 +0.0% SLG 5.71 +0.0% CASA 0.060 +0.0% DRY 0.215 +0.0% SOMA 0.560 +0.0% PWRO 0.025 +0.0% OMI 0.250 +0.0% EMR 0.100 +0.0% PDN 7.10 +0.0% GOLD 4201.80 +0.8% SILVER 58.03 +1.5% COPPER 6.63 +1.2% OIL 95.64 −2.4% PALLADIUM 1124.50 −0.3% LIB 0.720 +0.0% NPR 0.620 +0.0% QZM 0.380 +0.0% BVA 0.760 +0.0% ONAU 0.520 +0.0% FMR 0.225 +0.0% GSVR 0.340 +0.0% PHNM 0.340 +0.0% SLG 5.71 +0.0% CASA 0.060 +0.0% DRY 0.215 +0.0% SOMA 0.560 +0.0% PWRO 0.025 +0.0% OMI 0.250 +0.0% EMR 0.100 +0.0% PDN 7.10 +0.0%

Healthcare

Page 53
  1. Mar 04, 2026 · 17:00 · CPH

    Cipher Pharmaceuticals Schedules Q4 & Fiscal 2025 Earnings Release and Conference Call

    Cipher Pharmaceuticals Schedules Q4 & Fiscal 2025 Earnings Release and Conference Call

    01
  2. Mar 04, 2026 · 16:36 · SPLY

    Safe Supply testing Nirlab Nirlight devices in field

    Safe Supply testing Nirlab Nirlight devices in field

    02
  3. Mar 04, 2026 · 16:23 · SVA

    Sernova arranges $7.1-million in financings

    Sernova arranges $7.1-million in financings

    03
  4. Mar 04, 2026 · 07:09 · SPLY

    Safe Supply Confirms NIRLAB Drug Analysis Devices Actively Deployed and Under Field Evaluation by Government Stakeholders

    Safe Supply Confirms NIRLAB Drug Analysis Devices Actively Deployed and Under Field Evaluation by Government Stakeholders

    04
  5. Mar 04, 2026 · 07:05 · FRX

    Fennec Pharmaceuticals Announces Clinical Research Collaboration with Tampa General Hospital Cancer Institute

    Fennec Pharmaceuticals Announces Clinical Research Collaboration with Tampa General Hospital Cancer Institute

    05
  6. Mar 04, 2026 · 07:02 · SVA

    Sernova Biotherapeutics Strengthens Balance Sheet with $7.1 Million in Financings Plus Net Retirement of a Cumulative $17 Million of Debt Subject to Shareholder Approval

    Sernova Biotherapeutics Strengthens Balance Sheet with $7.1 Million in Financings Plus Net Retirement of a Cumulative $17 Million of Debt Subject to Shareholder Approval

    06
  7. Mar 04, 2026 · 03:54 · 4565

    Nxera Pharma Submits Marketing Authorization Application for Daridorexant in South Korea

    Nxera Pharma Submits Marketing Authorization Application for Daridorexant in South Korea

    07
  8. Mar 03, 2026 · 19:07 · DHT

    DRI Healthcare Reports Fourth Quarter and Annual 2025 Results

    DRI Healthcare Reports Fourth Quarter and Annual 2025 Results

    08
  9. Mar 03, 2026 · 18:54 · PINK

    Perimeter receives FDA premarket approval for Claire

    Perimeter receives FDA premarket approval for Claire

    09
  10. Mar 03, 2026 · 18:44 · QIPT

    Quipt Home holders OK acquisition by Kingswood, Forager

    Quipt Home holders OK acquisition by Kingswood, Forager

    10
  11. Mar 03, 2026 · 17:24 · PHRM

    Pharmather to expand PharmaPatch platform

    Pharmather to expand PharmaPatch platform

    11
  12. Mar 03, 2026 · 17:06 · PINK

    Perimeter Medical Imaging AI's 'Claire' Becomes First FDA-approved AI-Enabled Imaging Device for Breast Cancer Surgery

    Perimeter Medical Imaging AI's 'Claire' Becomes First FDA-approved AI-Enabled Imaging Device for Breast Cancer Surgery

    12
  13. Mar 03, 2026 · 17:00 · QIPT

    Quipt Home Medical Announces Voting Results From Special Meeting of Shareholders

    Quipt Home Medical Announces Voting Results From Special Meeting of Shareholders

    13
  14. Mar 03, 2026 · 16:57 · ASEP

    ASEP Medical arranges $1.16-million LIFE offering

    ASEP Medical arranges $1.16-million LIFE offering

    14
← Newer Older →